Medimprint develops innovative, non-lesion medical devices, for clinical research in brain tumors and neurodegenerative diseases. Based on a new concept, “the brain tissue imprint”, Medimprint’s products are the new generation of companion medical devices for personalized and targeted therapies. The non-lesion feature of this concept allows an exclusive in vivo access to :
– Tumor heterogeneity
– Peritumoral regions
– Neurodegenerative regions for poly-omic molecular analyses.
Medimprint’s technology breakthrough relies on the integration of functionalized silicon chips to surgical stylet for atraumatic sampling. Through an original « hide and display» principle, the brief and specific interaction of silicon with brain tissue enables a simple apposition contact and the collection of spatially-oriented imprints.
The innocuity of these new medical devices has been recently validated in a phase 0 clinical trial.
Company’s Keywords:
neurodegenerative diseases, tissue imprint, molecular investigation, tumor heterogeneity
<7
<
<2016
Your request has been submitted successfully.
Own or work here?